BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33539064)

  • 1. NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay.
    Peier A; Ge L; Boyer N; Frost J; Duggal R; Biswas K; Edmondson S; Hermes JD; Yan L; Zimprich C; Sadruddin A; Kristal Kaan HY; Chandramohan A; Brown CJ; Thean D; Lee XE; Yuen TY; Ferrer-Gago FJ; Johannes CW; Lane DP; Sherborne B; Corona C; Robers MB; Sawyer TK; Partridge AW
    ACS Chem Biol; 2021 Feb; 16(2):293-309. PubMed ID: 33539064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing Cell-Permeable Macrocyclic Peptides.
    Appiah Kubi G; Dougherty PG; Pei D
    Methods Mol Biol; 2019; 2001():41-59. PubMed ID: 31134566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Cell Penetration of Cyclic Peptides.
    Dougherty PG; Sahni A; Pei D
    Chem Rev; 2019 Sep; 119(17):10241-10287. PubMed ID: 31083977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome Click Membrane Permeability Assay for Identifying Permeable Peptides.
    Desai TJ; Habulihaz B; Cannon JR; Chandramohan A; Kaan HYK; Sadruddin A; Yuen TY; Johannes C; Thean D; Brown CJ; Lane DP; Partridge AW; Evers R; Sawyer TK; Hochman J
    Pharm Res; 2021 May; 38(5):843-850. PubMed ID: 33723794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
    Qian Z; Rhodes CA; McCroskey LC; Wen J; Appiah-Kubi G; Wang DJ; Guttridge DC; Pei D
    Angew Chem Int Ed Engl; 2017 Feb; 56(6):1525-1529. PubMed ID: 28035784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Click Chemistry for Cyclic Peptide Drug Design.
    Rashad AA
    Methods Mol Biol; 2019; 2001():133-145. PubMed ID: 31134571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
    Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
    Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting across the cell membrane: an overview for small molecules, peptides, and proteins.
    Yang NJ; Hinner MJ
    Methods Mol Biol; 2015; 1266():29-53. PubMed ID: 25560066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angler Peptides: Macrocyclic Conjugates Inhibit p53:MDM2/X Interactions and Activate Apoptosis in Cancer Cells.
    Philippe GJ; Mittermeier A; Lawrence N; Huang YH; Condon ND; Loewer A; Craik DJ; Henriques ST
    ACS Chem Biol; 2021 Feb; 16(2):414-428. PubMed ID: 33533253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.
    González-Muñiz R; Bonache MÁ; Pérez de Vega MJ
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.
    Bode SA; Thévenin M; Bechara C; Sagan S; Bregant S; Lavielle S; Chassaing G; Burlina F
    Chem Commun (Camb); 2012 Jul; 48(57):7179-81. PubMed ID: 22692031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the properties of short peptides conjugated with cell-penetrating peptides on their internalization into cells.
    Matsumoto R; Okochi M; Shimizu K; Kanie K; Kato R; Honda H
    Sci Rep; 2015 Aug; 5():12884. PubMed ID: 26256261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Design of Cell-Penetrating Foldamers.
    Yokoo H; Misawa T; Demizu Y
    Chem Rec; 2020 Sep; 20(9):912-921. PubMed ID: 32463155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.
    Liu J; Afshar S
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design Principles for Intestinal Permeability of Cyclic Peptides.
    Mathiowetz AM
    Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Subcellular Protein Delivery Using Cleavable Cyclic Cell-Penetrating Peptides.
    Schneider AFL; Wallabregue ALD; Franz L; Hackenberger CPR
    Bioconjug Chem; 2019 Feb; 30(2):400-404. PubMed ID: 30616339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled Peptides.
    Wu Y; Kaur A; Fowler E; Wiedmann MM; Young R; Galloway WRJD; Olsen L; Sore HF; Chattopadhyay A; Kwan TT; Xu W; Walsh SJ; de Andrade P; Janecek M; Arumugam S; Itzhaki LS; Lau YH; Spring DR
    ACS Chem Biol; 2019 Mar; 14(3):526-533. PubMed ID: 30702850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
    Buckton LK; Rahimi MN; McAlpine SR
    Chemistry; 2021 Jan; 27(5):1487-1513. PubMed ID: 32875673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.